Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-07 4:17 pm Purchase |
2025-04-01 | 13G | GRI Bio, Inc. GRI |
Mitchell P. Kopin | 40,261 4.990% |
40,261 (New Position) |
Filing History |
| 2024-02-13 5:17 pm Purchase |
2023-12-31 | 13G | GRI Bio, Inc. GRI |
Altium Capital Management LLC | 5,743 4.990% |
4,923 (+600.00%) |
Filing History |
| 2023-05-02 8:23 pm Purchase |
2023-04-24 | 13G | GRI Bio, Inc. GRI |
Altium Capital Management LLC | 820 9.990% |
820 (New Position) |
Filing History |
| 2023-05-02 4:05 pm Purchase |
2023-04-21 | 13G | GRI Bio, Inc. GRI |
TEP Biotech LLC | 132 6.930% |
132 (New Position) |
Filing History |
| 2023-04-25 4:19 pm Purchase |
2023-04-21 | 13D | GRI Bio, Inc. GRI |
Chaturvedi Vipin | 111 5.820% |
111 (New Position) |
Filing History |
| 2023-04-25 4:19 pm Purchase |
2023-04-21 | 13D | GRI Bio, Inc. GRI |
Agro Albert | 111 5.820% |
111 (New Position) |
Filing History |
| 2023-04-25 4:18 pm Purchase |
2023-04-21 | 13D | GRI Bio, Inc. GRI |
Hertz Walter Marc | 249 13.040% |
249 (New Position) |
Filing History |
| 2023-02-13 4:30 pm Sale |
2022-12-31 | 13G | Vallon Pharmaceuticals, Inc. VLON |
Lind Global Fund II LP | 250 0.100% |
-35,900 (-99.31%) |
Filing History |
| 2023-01-30 09:09 am Sale |
2022-12-31 | 13G | Vallon Pharmaceuticals, Inc. VLON |
BIGGER CAPITAL FUND L P | 0 0.000% |
-24,667 (Position Closed) |
Filing History |
| 2022-12-27 11:09 am Sale |
2022-12-14 | 13G | Vallon Pharmaceuticals, Inc. VLON |
Markey John | 0 0.000% |
-28,316 (Position Closed) |
Filing History |
| 2022-09-28 5:47 pm Purchase |
2022-09-28 | 13G | Vallon Pharmaceuticals, Inc. VLON |
Markey John | 28,316 8.100% |
28,316 (New Position) |
Filing History |
| 2022-05-23 5:00 pm Purchase |
2022-05-17 | 13G | Vallon Pharmaceuticals, Inc. VLON |
Lind Global Fund II LP | 36,150 9.900% |
36,150 (New Position) |
Filing History |
| 2022-05-23 4:30 pm Purchase |
2022-05-13 | 13G | Vallon Pharmaceuticals, Inc. VLON |
BIGGER CAPITAL FUND L P | 24,667 5.300% |
24,667 (New Position) |
Filing History |
| 2022-05-18 12:34 pm Purchase |
2022-05-17 | 13G | Vallon Pharmaceuticals, Inc. VLON |
Lincoln Park Capital Fund LLC | 35,008 9.990% |
35,008 (New Position) |
Filing History |
| 2022-02-17 3:29 pm Purchase |
2021-12-31 | 13G | Vallon Pharmaceuticals, Inc. VLON |
Malnik Dov | 16,993 7.500% |
16,993 (New Position) |
Filing History |
| 2022-02-14 9:41 pm Purchase |
2021-12-31 | 13G | Vallon Pharmaceuticals, Inc. VLON |
Arcturus Therapeutics Holdings Inc. ARCT |
28,125 12.380% |
28,125 (New Position) |
Filing History |
| 2021-03-15 7:51 pm Unchanged |
2021-02-09 | 13D | Vallon Pharmaceuticals, Inc. VLON |
SALMON Pharma GmbH | 50,793 22.400% |
0 (Unchanged) |
Filing History |
| 2021-02-12 6:02 pm Purchase |
2021-02-09 | 13D | Vallon Pharmaceuticals, Inc. VLON |
SALMON Pharma GmbH | 50,793 20.500% |
50,793 (New Position) |
Filing History |